Clene Inc. (CLNN)

Clene Inc. (CLNN) is a Packaged Foods company in the Consumer Defensive sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $47M; returns 1 day +0.0%, 1 week +25.2%, 1 year -52.4%.

Clene Inc. (CLNN) is a late clinical-stage biopharmaceutical company focused on developing clean-surfaced nanotechnology (CSN) therapeutics for neurodegenerative diseases. The company's primary focus is on improving mitochondrial health and protecting neuronal function. Clene is not yet a commercial-stage company.

Groups CLNN belongs to

• Biotechnology
• Biopharmaceutical
• Neuroscience
• Clinical Stage
• Clinical Stage Biotech
• Neurological Disorders
• CNS Disorders
• Healthcare
• Rare Diseases
• Life Sciences

CLNN financial model: income statement, cash flow and balance sheet